CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale Chief Executive Officer sold 25,000 shares at an average $64.88 ($1,621,894)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Medical Officer gave up 2,527 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- 144 Insider Sale of Securities
Page 13 of 45 · 883 filings